Argent BioPharma Limited (ASX:RGT)
Australia
· Delayed Price · Currency is AUD 0.1200
0.00 (0.00%)
At close: May 15, 2025, 4:00 PM AEST
Argent BioPharma Balance Sheet
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2015 - 2019 |
| Cash & Equivalents | 0.72 | 0.7 | 0.24 | 1.89 | 5.43 | 1.87 | Upgrade
|
| Cash & Short-Term Investments | 0.72 | 0.7 | 0.24 | 1.89 | 5.43 | 1.87 | Upgrade
|
| Cash Growth | -88.92% | 193.08% | -87.29% | -65.28% | 190.03% | -20.42% | Upgrade
|
| Accounts Receivable | 0.34 | 0.14 | 0.21 | 0.74 | 0.84 | - | Upgrade
|
| Other Receivables | - | 0.34 | 0.32 | 1.2 | 1.51 | 0.47 | Upgrade
|
| Receivables | 0.34 | 0.48 | 0.53 | 1.94 | 2.35 | 0.52 | Upgrade
|
| Inventory | 0.33 | 0.88 | 1.36 | 1.84 | 0.87 | 0.4 | Upgrade
|
| Prepaid Expenses | 0.66 | 0.69 | 0.4 | 0.8 | 0.55 | 0.07 | Upgrade
|
| Other Current Assets | - | - | - | - | 0.28 | 0.36 | Upgrade
|
| Total Current Assets | 2.05 | 2.74 | 2.53 | 6.46 | 9.48 | 3.23 | Upgrade
|
| Property, Plant & Equipment | 1.01 | 6.72 | 7.45 | 8.8 | 7.14 | 4.02 | Upgrade
|
| Long-Term Investments | - | 1.33 | - | 0.16 | 0.56 | 0.67 | Upgrade
|
| Goodwill | - | - | - | 3.15 | 7.05 | - | Upgrade
|
| Other Long-Term Assets | 0 | - | - | - | - | - | Upgrade
|
| Total Assets | 3.06 | 10.79 | 9.98 | 18.56 | 24.24 | 7.93 | Upgrade
|
| Accounts Payable | 4.57 | 0.96 | 2.19 | 2.52 | 1.22 | 2 | Upgrade
|
| Accrued Expenses | - | 0.35 | 0.54 | 0.69 | 0.38 | 0.56 | Upgrade
|
| Short-Term Debt | 8.38 | 8.68 | 9.18 | 2.1 | 4.03 | - | Upgrade
|
| Current Portion of Leases | 0.24 | 0.22 | 0.19 | 0.28 | 0.21 | 0.05 | Upgrade
|
| Current Unearned Revenue | - | 0.55 | 0.66 | 1.81 | - | 0.1 | Upgrade
|
| Other Current Liabilities | - | 1.42 | 0.58 | 0.31 | 0.28 | 0.26 | Upgrade
|
| Total Current Liabilities | 13.19 | 12.18 | 13.33 | 7.71 | 6.13 | 2.97 | Upgrade
|
| Long-Term Leases | 0.73 | 0.82 | 0.38 | 1.97 | 1.77 | 1.85 | Upgrade
|
| Long-Term Unearned Revenue | - | 3.6 | 4.28 | 3.68 | 2.51 | - | Upgrade
|
| Other Long-Term Liabilities | 0.02 | 0.02 | 0.02 | 0.02 | - | 0.02 | Upgrade
|
| Total Liabilities | 13.94 | 16.61 | 18.02 | 13.38 | 10.41 | 4.83 | Upgrade
|
| Common Stock | 129.58 | 123.29 | 103.69 | 97.25 | 84.51 | 60.15 | Upgrade
|
| Retained Earnings | -141.83 | -129.67 | -119.17 | -98.35 | -78 | -62.13 | Upgrade
|
| Comprehensive Income & Other | 1.37 | 1.23 | 8.08 | 6.93 | 7.32 | 5.08 | Upgrade
|
| Total Common Equity | -10.88 | -5.15 | -7.4 | 5.84 | 13.83 | 3.11 | Upgrade
|
| Minority Interest | - | -0.67 | -0.63 | -0.66 | -0.01 | -0.01 | Upgrade
|
| Shareholders' Equity | -10.88 | -5.82 | -8.03 | 5.18 | 13.83 | 3.09 | Upgrade
|
| Total Liabilities & Equity | 3.06 | 10.79 | 9.98 | 18.56 | 24.24 | 7.93 | Upgrade
|
| Total Debt | 9.35 | 9.72 | 9.75 | 4.35 | 6.02 | 1.9 | Upgrade
|
| Net Cash (Debt) | -8.63 | -9.02 | -9.51 | -2.47 | -0.58 | -0.03 | Upgrade
|
| Net Cash Per Share | -0.17 | -0.24 | -3.23 | -0.96 | -0.31 | -0.02 | Upgrade
|
| Filing Date Shares Outstanding | 54.27 | 48.41 | 4.43 | 2.85 | 2.39 | 1.63 | Upgrade
|
| Total Common Shares Outstanding | 54.27 | 45.28 | 3.35 | 2.73 | 2.32 | 1.58 | Upgrade
|
| Working Capital | -11.14 | -9.44 | -10.8 | -1.25 | 3.35 | 0.26 | Upgrade
|
| Book Value Per Share | -0.20 | -0.11 | -2.21 | 2.14 | 5.96 | 1.97 | Upgrade
|
| Tangible Book Value | -10.88 | -5.15 | -7.4 | 2.69 | 6.79 | 3.11 | Upgrade
|
| Tangible Book Value Per Share | -0.20 | -0.11 | -2.21 | 0.99 | 2.93 | 1.97 | Upgrade
|
| Machinery | 0.1 | 9.79 | 10.04 | 9.07 | 1.94 | 1.96 | Upgrade
|
| Construction In Progress | - | - | - | - | 4.44 | 1.13 | Upgrade
|
Updated Feb 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.